The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
LARIMAR THERAPEUTICS INC COM 517125100 6,256 292,184 SH   SOLE   292,184 0 0
MIRAGEN THERAPEUTICS INC COM NEW 92790C104 3,446 209,505 SH   SOLE   209,505 0 0
F-STAR THERAPEUTICS INC COM 30315R107 5,675 574,996 SH   SOLE   574,996 0 0
SNAP INC CL A 83304A106 12,295 245,559 SH   SOLE   0 0 245,559
TRANSLATE BIO INC COM 89374L104 48,960 2,656,517 SH   SOLE   2,656,517 0 0
BICYCLE THERAPEUTICS PLC SPONSORED ADS 088786108 10,998 612,696 SH   SOLE   612,696 0 0
ROKU INC COM CL A 77543R102 19,160 57,707 SH   SOLE   57,707 0 0
DRAFTKINGS INC COM CL A 26142R104 339,143 7,284,008 SH   SOLE   7,284,008 0 0